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Summary
PGL1, a gene responsible for hereditary paragangliomas
of the head and neck, recently was mapped to a 2-cM
interval on chromosome 11q22-q23, by linkage and
haplotype-sharing analysis of a large multibranch Dutch
family. We determined the disease-linked haplotype, as
defined by 13 markers encompassing a large interval on
11q21-q23, in 10 additional families ascertained from
the same geographical locale. Alleles were identical for
six contiguous markers, spanning a genetic distance of
6 cM and containing PGL1. Despite this strong indi-
cation of a common ancestor, no kinships between the
families could be demonstrated through genealogical
surveys going back to 1800 A.D. We conclude that a
single ancestral mutation is responsible for most, if not
all, hereditary paragangliomas, in this region of The
Netherlands, and that strong founder effects may exist
at the PGL1 locus.
Introduction
Paragangliomas are rare, usually benign tumors of the
extra-adrenal paraganglion tissue associatedwith the au-
tonomous nervous system (Parry et al. 1982). Most
paragangliomas occur in the head and neck region,
where they may lead to cranial nerve deficit. Charac-
teristically, the tumor progresses slowly, and, although
the age at onset is variable, most patients develop symp-
toms after puberty. Familial nonchromaffin paragan-
gliomas of the head and neck (HN-paragangliomas;
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MIM 168000) are inherited as an autosomal dominant
disease with reduced penetrance (Van Baars et al. 1982;
McCaffrey et al. 1994). Affected offspring are observed
only after paternal transmission, which is considered to
be evidence that the underlying gene defect is subject to
genomic imprinting (Van der Mey et al. 1989).
Linkage analysis of a single large Dutch pedigree
mapped the gene, termed “PGL1,” to 11q22-q23 (Heu-
tink et al. 1992). This result was replicated in additional
families (Heutink et al. 1994) and was confirmed in
North American families (Baysal et al. 1997a;Milunsky
et al. 1997), but the detected recombination events did
not map the gene to an interval more precise than ∼10
cM. We recently identified a common ancestor, born in
1776, of three families originating from the same geo-
graphical region, including the family in which the orig-
inal linkage was found. A 2-cM haplotype, presumably
containing PGL1, was shared among all patients in the
two most recent generations of these families (Van
Schothorst et al. 1996). Although a second locus has
been implicated to reside on 11q13 in one other Dutch
paraganglioma family (Mariman et al. 1995), all infor-
mative families analyzed to date have revealed linkage
evidence for only the distal PGL1 locus on 11q22-q23
(Heutink et al. 1994; Baysal et al. 1997a; Milunsky et
al. 1997).
Recently, another 10 families with HN-paragan-
gliomas were ascertained from the same geographical
region as that from which the large PGL1-linked family
originated. Assuming that such conspicuous geograph-
ical clustering of a rare disorder might reflect a founder
effect, which could be exploited for further gene local-
ization, we performed a genealogical survey and deter-
mined the disease-linked haplotypes for all 10 families.
Although no family relationships could be demonstrated
by genealogy, haplotype analysis provided strong evi-
dence for a common founder in this population.
Subjects and Methods
Family Ascertainment
Since 1950, 183 patients with HN-paragangliomas
have been referred to our Ear, Nose, and Throat De-
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partment. Queries were sent to those patients with a
recorded family history of HN-paragangliomas, ena-
bling us to ascertain 27 pedigrees with a total of at least
142 patients. Three families (FGT1, FGT8, and FGT9)
originating from the central western region of The Neth-
erlands could be traced to a common ancestor (Van
Schothorst et al. 1996), and the resulting single kindred
was renamed “FGT189.” Fourteen other families orig-
inated from the same province as that of family FGT189,
and we obtained DNA samples in order to reconstruct
the disease haplotype from 10 of these families. FGT3,
FGT11, and FGT18 have been partially described else-
where (Van der Mey et al. 1989; Hart and Maartense
1992; Heutink et al. 1994), and the other families are
reported here for the first time.
Disease Ascertainment
Diagnosis of HN-paragangliomas was based on clin-
ical signs and, for most patients, was confirmed by his-
tological or radiological investigation. Twelve probable
affected progenitors were identified by evaluation of
their medical history. Ten of these putative patients, of
whom two died during surgical intervention, are known
to have had lateral neck masses. The other two are
known to have had ear complaints leading to bleeding
or loss of facial nerve function.
Genealogy Analysis
Familial ancestries were traced back starting from the
oldest known common ancestor of affected family mem-
bers and included both the paternal and maternal lines.
Civil registration data on generations beyond the year
1800 could not be retrieved. Three ancestral lines were
not completed: in family FGT27, data on one generation
in the maternal line were not available; in family FGT32,
an in-married spouse, born in approximately 1850,
could not be traced; in FGT20, the genealogical search
was thwarted by the existence of an adopted ancestor.
DNA Isolation and PCR Analysis
Blood samples were collected, and genomic DNA was
isolated from peripheral blood lymphocytes (Miller et
al. 1988). PCR and gel-electrophoresis conditions for the
visualization of microsatellite polymorphisms were as
described elsewhere (Van Schothorst et al. 1996). All
primer sequences for these markers are retrievable from
the Genome Database, and all oligonucleotides were
manufactured by Isogen.
Haplotype Analysis
For haplotype analysis, we used a marker order de-
scribed by Van Schothorst et al. (1996). The genetic map
(Litt et al. 1995; Dib et al. 1996) was complemented
with data obtained by physical mapping of the region
between markers D11S897 and D11S4111 (Baysal et al.
1997b). The markers selected covered a genetic distance
of ∼50 cM. Allele lengths were determined by use of an
M13 sequence as a reference. Allele frequencies in the
control population were determined for 41 in-married
spouses, of whom 20 were from family FGT189 and 21
from families with familial atypical multiple-mole mel-
anoma (FAMMM) syndrome. These FAMMM-syn-
drome families originated from the same area as FGT189
(Gruis et al. 1995). Allele lengths and frequencies thus
determined were not appreciably different from those
reported in the Genome Database.
Results
Clinical Description and Inheritance Patterns in 10
HN-Paraganglioma Families
A total of 63 HN-paraganglioma patients, of whom
42 had complete medical records, were identified in the
10 families reported here (table 1). The carotid bifur-
cation was the most frequently affected site (57% of all
HN-paragangliomas). Multiple paragangliomas oc-
curred in 66% of the patients, as expected for inherited
cases (McCaffrey et al. 1994). Three patients, from dif-
ferent families, had developed a paraganglioma of the
adrenal gland (pheochromocytoma). In family FGT11,
primary hypothyroidism occurred in a father and his
daughter, who both also had HN-paragangliomas. No
affected offspring of female carriers were observed, and
all affected family members received the disease gene
from their father, which is consistent with the hypothesis
of genomic imprinting of PGL1 (Van der Mey et al.
1989). Remarkably, 42 patients received the gene from
their grandfather, whereas only 2 patients received it
from their grandmother (for 19 patients, the transmit-
ting grandparent could not be determined [data not
shown]).
Haplotype Analysis
Blood samples were obtained from 136 family mem-
bers, including 33 patients (table 1). DNA was geno-
typed at 13 markers encompassing an ∼50-cM interval
on 11q13-q24. Previously, we had identified a three-
marker haplotype of ∼2 cM, defined by markers
D11S1792, D11S1327, and D11S908, which was con-
served among all the patients from a large multibranch
family, FGT189 (summarized in fig. 1). However, amuch
larger haplotype, of ∼10 cM, defined by markers be-
tween D11S876 and D11S4092, was shared among the
patients from branches C–K, and this sharing extended
beyond marker CD3D in branches E–H. We compared
this so-called E/H-haplotype with the disease-linkedhap-
lotypes of the 10 families included in this study (table
2). None of the families contained recombinants be-
tween the disease and any marker mapping between
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Table 1
Clinical Data from 10 HN-Paraganglioma Kindreds
FAMILY
NO. OF PATIENTS
KINSHIP OF PATIENTS
NO. OF TUMORSc
Totala Verifiedb Genotyped CBT VBT JTT PH
FGT3 13 8 4 Cousins, father-sibs 6 4 7 0
FGT5 5 4 3 Cousins, sibs, father-son 5 2 0 0
FGT11 2 2 2 Father-daughter 1 0 2 0
FGT17 7 4 2 Cousins, sibs 3 0 2 1
FGT18 18 13 10 Cousins, father-sibs 15 2 0 0
FGT20 3 2 2 Sibs 4 3 1 1
FGT25 7 5 5 Cousins, father-sibs 4 1 1 0
FGT27 4 1 2 Father-sibs 1 0 0 1
FGT29 2 1 2 Father-daughter 1 0 1 0
FGT32 2 2 1 Cousins 2 3 3 0
Total 63 42 33 42 15 17 3
a Total number identified anamnestically.
b As documented by medical records.
c CBT  carotid body tumor; VBT  vagale body tumor; JTT  jugulo-tympanicum tumor; and
PH  pheochromocytoma.
D11S1647 and D11S908. These markers previously had
been shown to be recombinant in two other indepen-
dently ascertained families (Van Schothorst et al. 1996;
Baysal et al. 1997a). All patients shared a haplotype
defined by six markers and bracketed by D11S927 and
D11S908. This haplotype was not observed among 41
unrelated individuals (82 chromosomes) from the same
geographical region, supporting the hypothesis that all
patients in these 11 families are genetically identical by
descent. Notably, several families—namely, FGT11,
FGT18, and FGT20—appear to share with family
FGT189 a very large region that includes all but the
most distant markers tested (table 2).
Genealogy
Records on 72 ancestors of the 10 families were re-
trievable. These ancestors were born between 1770 A.D.
and 1830 A.D. and originated from several rural areas
of the central western region of The Netherlands, all
within a radius of ∼40 km. Despite this strong geo-
graphical clustering, none of the families studied were
proved to be interrelated.
Discussion
HN-paragangliomas usually follow a slow, benign
natural course and generally occur at age 118 years
(Parry et al. 1982; Van Baars et al. 1982; Van Gils et
al. 1992). As a result, they are not expected to impede
reproductive fitness. By analyzing pooled data from
Dutch pathologic laboratories, we estimated an annual
rate of 0.11/100,000 (Oosterwijk et al. 1996). Lack et
al. (1977) found 69 paragangliomas among 600,000
surgical cases seen at the Sloan-KetteringMemorial Can-
cer Center, during 1937–75. If a relevant-population size
of 1–2 million is assumed, this would suggest a com-
parable incidence rate. However, because of the late on-
set and benign course of the disease, an unknown pro-
portion of the patients will not be hospitalized, leading
to an underestimation of disease incidence (Van Gils et
al. 1992). For similar reasons, the proportion of familial
cases will be underestimated. This proportion has been
reported to be 5%–10% (Grufferman et al. 1980; Parry
et al. 1982), but in The Netherlands we are seeing a
more conspicuous occurrence of familial cases (J. C. Jan-
sen, unpublished data). Therefore, a founder effect is not
unexpected, in particular because this also has been ob-
served for a variety of other hereditary diseases in The
Netherlands (Buyle et al. 1993; Houwen et al. 1994;
Gruis et al. 1995; Taschner et al. 1995; Freimer et al.
1996; Peelen et al. 1997).
Recently, we described a 2-cM haplotype shared by
all patients in the most recent two generations of the
large multibranch family FGT189 (Van Schothorst et al.
1996). However, conservation of this haplotype ex-
tended over much larger regions in a subset of the pa-
tients (the E/H-haplotype; fig. 1). We have shown in this
study that parts of this particular haplotype are con-
served in another 10 families originating from within a
radius of ∼40 km from the town in which FGT189 orig-
inated. The minimal region shared with the E/H-hap-
lotype covers ∼6 cM and encompasses the previously
identified 2-cM haplotype presumably containing the
PGL1 locus. This haplotype was not detected in 82 chro-
mosomes from unrelated individuals from the same re-
gion. Under Hardy-Weinberg equilibrium, the popula-
tion frequency of this haplotype would be 0.04%,
making it highly unlikely that this haplotype is linked
by chance to PGL1 in 11 families. Since we included 10
of the 14 HN-paraganglioma families ascertained from
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Figure 1 A, Abbreviated version of the pedigree structure of extended family FGT189, described in detail in the study by Van Schothorst
et al. (1996). The family was arbitrarily subdivided into branches A–K. Blackened circles represent sibships in which at least one patient has
been verified by review of medical records. The number of haplotyped patients is indicated below each branch. B, Genetic map of markers
used in this study. Distances are in centimorgans (cM). The underlined markers showed allele sharing in all patients of family FGT189. The
markers in italics are provided for orientation.
this region, these data therefore strongly indicate that a
single ancestral mutation in PGL1 is responsible formost
paragangliomas occurring in the central western region
of The Netherlands. The genealogies of these 10 families
do not link any of them to FGT189, suggesting that this
mutation must be x200 years old.
In view of the age of this PGLl mutation, it is re-
markable that several families (FGT11, FGT18, and
FGT20) share a region of 115 cM with the E/H-hap-
lotype of FGT189. The genetic distance between the hap-
lotyped patients from families FGT11, FGT18, and
FGT20 and those from branches E–H of family FGT189
must be x16 meioses (fig. 1A). We have suggested a
deficit of recombination events involving the disease-
linked haplotype, in paraganglioma families (Van
Schothorst et al. 1996), but this hypothesis lacks statis-
tical support, so far. In fact, such events must have oc-
curred more recently in branches A and B of family
FGT189, since the haplotype sharing between these
branches is only ∼2 cM. Moreover, a more than twofold
excess of female versus male recombination has been
reported for this region of chromosome 11 (Litt et al.
1995). Thus, the size of the conserved haplotype might
be explained in part by the overrepresentation of male
transmission in our families. Also, strong haplotype con-
servation has been reported for families with FAMMM
syndrome from the same geographical area (Gruis et al.
1995), as well as for other founder populations (Peltonen
and Uusitalo 1997), and therefore might not be uncom-
mon. Nevertheless, because of the finding that genomic
imprinting may interfere with sex-specific recombination
rates (Paldi et al. 1995; Robinson and Lalande 1995),
it is tempting to speculate that the PGL1 mutation that
is responsible for HN-paragangliomas also affects re-
combination rates in this region of chromosome 11.
The overrepresentation of paternal and grandpaternal
transmission that we have noted here might be explained
by an ascertainment bias, owing to the fact that HN-
paragangliomas develop only after paternal transmission
(Van der Mey et al. 1989). Even though PGL1-carrying
females would have the same chance, on average, of
having affected grandchildren as PGL1-carrying males,
their affected grandchildren are less likely to be recog-
nized as hereditary cases, because they inherit the gene
from their nonpenetrant father. This would imply that
an unknown proportion of allegedly sporadic paragan-
glioma cases are in fact hereditary.
Another interesting feature of this founder mutation
in PGL1 is its apparent ability to predispose to pheo-
chromocytomas (paraganglioma of the adrenal gland).
We detected five cases of this rare tumor in the 11 fam-
ilies studied here (table 1; also see Van Gils et al. 1992),
which confirms suggestions, reported elsewhere, of an
association with HN-paragangliomas (Sato et al. 1974;
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Table 2
Disease Haplotypes of 10 HN-Paraganglioma Families, Compared with the E/H-Haplotype of Family FGT189
MARKER
SIZE OF LINKED ALLELE IN FAMILYa
(bp)
FREQUENCYb
(%)FGT189 FGT11 FGT18 FGT20 FGT32 FGT25 FGT3 FGT17 FGT5 FGT26 FGT27
D11S527 159 159 147 157 151 159 157  151 155/159 165 147/157 161/155 16
D11S927 135 135 135 135 135 135 135 135 135 135 141/137 18
NCAM 126 126 126 126 126 126 126 126 126 126 126 7
DRD2 82 82 82 82 82 82 82 82 82 82 82 52
D11S560 87 87 87 87 87 87 87 ND 75/87 ND 77/87 4
D11S938 212 212 212 212 212 212 212 212 212 212 212 58
D11S1792 269 269 269 269 269 269 269 269 269 269 269 76
D11S1327 250 250 250 250 250 250 250 250 250 250 250 64
D11S908 147 147 147 147 147 147 147 147 149 149 151 38
D11S939 247 247 247 247 247 241 241 241 241 249 247 45
D11S490 159 159 159 159 161 149 167 159 159 149 159 32
CD3D 89 89 89 89 89 85 93  91 89/93 89 ND 89 27
D11S836 70 72 72 74 74 72 74  66 74 74 74/70 74 8
a Families are ordered according to decreasing overlap of the haplotype linked with that of family FGT189. Two allele lengths separated by
a plus sign () indicate a recombination event in that family; and two allele lengths separated by a slash (/) indicate that the phase is unknown.
ND  not determined.
b Frequency of alleles that define the linked E/H-haplotype (see text) in FGT189, as observed in the control population.
Bogdasarian and Lotz 1979). Thus, PGL1 might be
another factor in the already heterogeneous genetic
basis of familial pheochromocytomas (Woodward et
al. 1997).
Our finding of a strong founder effect at PGL1 con-
trasts with the haplotype analysis of North American
HN-paraganglioma families, in which no obvious, large
regions of allele sharing were apparent (Baysal et al.
1997a). This likely is due to the heterogeneous ethnic
background of the families in that study. The founder
effect reported here can now be exploited further for the
purpose of gene mapping, by analysis of haplotype shar-
ing across a densely spaced polymorphic marker map
covering the culprit 11q23 region and its immediately
flanking regions in additional hereditary HN-paragan-
glioma patients of Dutch origin.
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